41.86
                                            Schlusskurs vom Vortag:
              $41.19
            Offen:
              $41.16
            24-Stunden-Volumen:
                218.55K
            Relative Volume:
              0.73
            Marktkapitalisierung:
                $852.59M
            Einnahmen:
              $982.01M
            Nettoeinkommen (Verlust:
              $14.80M
            KGV:
              113.14
            EPS:
                0.37
            Netto-Cashflow:
                $37.02M
            1W Leistung:
              +1.97%
            1M Leistung:
              +6.92%
            6M Leistung:
                +121.72%
            1J Leistung:
              +76.62%
            Phibro Animal Health Corp Stock (PAHC) Company Profile
Firmenname
                  
                      Phibro Animal Health Corp
                    
                Sektor
                  Telefon
                  
                      201-329-7300
                    
                Adresse
                  
                      GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
                    
                Vergleichen Sie PAHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
|   
                          
                                PAHC
                            
                             Phibro Animal Health Corp | 41.86 | 1.67B | 982.01M | 14.80M | 37.02M | 0.37 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.10 | 63.79B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.23 | 43.49B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.18 | 40.30B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.03 | 23.21B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 453.53 | 20.59B | 3.08B | 1.24B | 1.07B | 25.61 | 
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-07-07 | Hochstufung | JP Morgan | Neutral → Overweight | 
| 2025-06-16 | Hochstufung | BNP Paribas Exane | Underperform → Neutral | 
| 2024-09-10 | Eingeleitet | JP Morgan | Neutral | 
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Underperform | 
| 2022-12-21 | Eingeleitet | ROTH Capital | Buy | 
| 2022-07-25 | Herabstufung | Barclays | Equal Weight → Underweight | 
| 2022-01-10 | Hochstufung | Barclays | Underweight → Equal Weight | 
| 2021-11-18 | Eingeleitet | Morgan Stanley | Equal-Weight | 
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral | 
| 2021-07-07 | Herabstufung | Barclays | Equal Weight → Underweight | 
| 2020-08-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight | 
| 2020-02-06 | Herabstufung | Gabelli & Co | Buy → Hold | 
| 2020-01-28 | Hochstufung | Barclays | Underweight → Equal Weight | 
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight | 
| 2019-08-29 | Bestätigt | BofA/Merrill | Underperform | 
| 2019-06-11 | Eingeleitet | Barclays | Underweight | 
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral | 
| 2019-05-09 | Hochstufung | Gabelli & Co | Hold → Buy | 
| 2017-08-23 | Fortgesetzt | BofA/Merrill | Underperform | 
| 2017-06-02 | Herabstufung | Credit Suisse | Outperform → Neutral | 
| 2016-12-15 | Eingeleitet | Piper Jaffray | Overweight | 
| 2016-11-11 | Herabstufung | Macquarie | Neutral → Underperform | 
| 2016-11-10 | Herabstufung | Gabelli & Co | Buy → Hold | 
| 2016-04-11 | Bestätigt | Guggenheim | Buy | 
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform | 
| 2016-01-15 | Herabstufung | Barclays | Overweight → Underweight | 
| 2015-09-30 | Eingeleitet | Gabelli & Co | Buy | 
| 2015-04-24 | Bestätigt | Barclays | Overweight | 
| 2015-04-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight | 
| 2014-05-06 | Eingeleitet | Barclays | Overweight | 
                    Alle ansehen
                     
                  
                Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten
Using flow based indicators on Phibro Animal Health CorporationMarket Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
Phibro Animal Health announces national launch of Restoris dental gel - TipRanks
BFI Co. sells Phibro Animal Health (PAHC) shares worth $437,486 By Investing.com - Investing.com India
BFI Co. sells Phibro Animal Health (PAHC) shares worth $437,486 - Investing.com
Phibro Animal Health (PAHC) Launches Innovative Dental Gel for D - GuruFocus
Phibro launches new dental gel treatment for dogs with periodontal disease - Investing.com
Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs - FinancialContent
Identifying reversal signals in Phibro Animal Health Corporation2025 Major Catalysts & Safe Capital Growth Plans - newser.com
Relative strength of Phibro Animal Health Corporation in sector analysisJuly 2025 Technicals & Long-Term Safe Investment Ideas - newser.com
How to integrate Phibro Animal Health Corporation into portfolio analysis toolsQuarterly Portfolio Report & Growth Focused Entry Reports - newser.com
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results - Yahoo Finance
What recovery options are there for Phibro Animal Health CorporationJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com
Evaluating Phibro Animal Health Corporation with trendline analysisBear Alert & Fast Moving Stock Trade Plans - newser.com
How Phibro Animal Health Corporation stock valuations compare to rivalsJuly 2025 Closing Moves & Advanced Swing Trade Entry Alerts - newser.com
Lobbying Update: $20,000 of PHIBRO ANIMAL HEALTH CORPORATION lobbying was just disclosed - Quiver Quantitative
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
How Phibro Animal Health Corporation stock performs in rising dollar environmentTrade Analysis Summary & Daily Entry Point Trade Alerts - Fundação Cultural do Pará
Why Phibro Animal Health Corporation stock appeals to dividend seekersWeekly Trade Report & Long-Term Safe Return Strategies - newser.com
Why Phibro Animal Health Corporation (PB8) stock stays undervaluedJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
Will Phibro Animal Health Corporation stock recover faster than marketTrade Signal Summary & Safe Investment Capital Preservation Plans - newser.com
Phibro Animal Health Corp. Hits New 52-Week High of $42.80 - Markets Mojo
Published on: 2025-10-26 19:57:12 - newser.com
Will Phibro Animal Health Corporation (PB8) stock outperform Dow JonesOptions Play & Daily Growth Stock Tips - newser.com
Published on: 2025-10-25 20:42:06 - newser.com
Jack Bendheim Sells 3,520 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock - MarketBeat
Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App